Research graph
References from Emergence of Macrolide-Resistant Bordetella pertussis , Peru, 2025. Local targets link to admitted publications; unresolved targets remain external evidence.
Pertussis vaccines: WHO position paper—September 2015.
2015 · External reference
Unresolved reference
External reference
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.
10.3389/fimmu.2025.1618883 · 2025 · External reference
Macrolide resistance in Bordetella pertussis: current situation and future challenges.
10.3390/antibiotics11111570 · 2022 · External reference
Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence.
10.1016/j.jinf.2026.106718 · 2026 · External reference
Emerging macrolide resistance in Bordetella pertussis in mainland China: findings and warning from the global pertussis initiative.
10.1016/j.lanwpc.2021.100098 · 2021 · External reference
Unresolved reference
External reference
Twenty-five years of pertussis outbreaks in the Peruvian Amazon: a call to strengthen equity in vaccination and control.
10.1016/j.lana.2025.101255 · 2025 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens.
10.1128/jcm.00601-11 · 2011 · External reference
A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
10.1128/jcm.38.3.1151-1155.2000 · 2000 · External reference
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.
10.1016/j.cmi.2024.08.016 · 2024 · External reference
Phenotypic diversity of Bordetella pertussis against trimethoprim/sulphamethoxazole in vitro tests.
10.1016/j.diagmicrobio.2024.116597 · 2025 · External reference
In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: a single-centre study in Zhejiang Province, China.
10.1016/j.jgar.2019.01.029 · 2019 · External reference
